VC Deals Mechio Inc. (dba Motiv), a San Francisco-based micro-wearables startup, has raised more than $8.6 million in Series A funding, according to a regulatory filing. Kleiner Perkins Caufield [...]
VC Deals Selecta Biosciences Inc., a Watertown, Mass.-based developer of targeted antigen-specific immune therapies, has raised $38 million in Series E funding. Existing shareholder OrbiMed [...]
VC Deals CeQur SA, a Swiss developer of insulin infusion solutions for people with diabetes, has raised $100 million in Series C funding. Woodford Investment Management and Arthurian Life [...]
VC Deals Editas Medicine, a Cambridge, Mass.-based genome editing company, has raised $120 million in Series B funding. Boris Nikolic led the round, on behalf of a U.S. investment company formed [...]
VC Deals LifeBond, an Israel-based developer of surgical sealants, has raised $27 million in Series D funding. Backers include Adams Street Partners, Sino Biopharmaceutical and return backers [...]
http://www.private-equityseasia.com/uploadedFiles/EventRedesign/Singapore/2013/May/16672006/Assets/Why_PE_Firms_are_betting_on_Red_Hot_SEA_25_2_2013.pdf
“Historically, China and India have been high on limited partners’ (LPs) radars, but increasingly we are seeing a shift in investment strategy.” – Luke Pais, Ernst & [...]
- 1
- 2